Activity value 62india Buyer&Supplier,Last transaction date:
2018-01-25Address: new no.7, old no.5, 17th street, arumbakkam,chennai, tamilnadu,pin-600106
The above chart presents the market trend analysis for gkm new pharma from 2017 to 2018.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2018, the company has completed 4 transactions, with a transaction quantity of 919.78 and a transaction weight of 19.78.
YearTransactionsQuantityWeight
Bill of lading data
<
1/15
>
Trade date
2018/01/25
B/L No.
——
Supplier
gkm new pharma
Buyers
carlton
POLs
——
PODs
——
Supply area
India
Purchas area
Sri Lanka
Weight
9.89kg
Amount
——
Hs code
30049090
Product tags
ail,ciment,ale
Product description
MEDICIMENTS, MIXED OR UNMIXED IN THE FORM OF RETAIL SALE, NES
Expand
Trade date
2018/01/25
B/L No.
——
Supplier
gkm new pharma
Buyers
carlton
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Sri Lanka
Weight
9.89kg
Amount
1575
Hs code
30049090
Product tags
ail,ciment,ale
Product description
MEDICIMENTS, MIXED OR UNMIXED IN THE FORM OF RETAIL SALE, NES
Expand
Trade date
2018/01/16
B/L No.
2236859
Supplier
gkm new pharma
Buyers
medmart pharma pvt ltd.
gkm new pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet,dasan,dasatinib.
According to the 52wmb.com global trade database, as of 2018-01-25, the company has completed 44 international trades,
with its main trading regions covering sri lanka,other etc.
The core products include HS30049039,HS30049090,HS29333990 etc,
often transported via chennai etc,
and its main trading partners are medmart pharma pvt ltd.,non commercial imports eg value less than rs.y articles considered asial nature decided by dgc,carlton.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on gkm new pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.